In this review, we discuss the clinical features and possible correlation to the seemingly diverse molecular alterations underlying FOXG1 syndrome, and explore up-to-date disease models, aiming to advance potential therapeutic avenues. The gene discussed is FOXG1; the disease is Down syndrome.